ArticleBlood advances2020

Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy.

Joanne E Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.